Cargando…
IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?
The role of insulin-like growth factor binding protein 2 (IGFBP2) in cancer is unclear. In general, IGFBP2 is considered to be oncogenic and its expression is often observed to be elevated in cancer. However, there are a number of conflicting reports in vitro and in vivo where IGFBP2 acts in a tumor...
Autores principales: | Pickard, Adam, McCance, Dennis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343188/ https://www.ncbi.nlm.nih.gov/pubmed/25774149 http://dx.doi.org/10.3389/fendo.2015.00025 |
Ejemplares similares
-
HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures
por: Pickard, Adam, et al.
Publicado: (2015) -
p300 Alters Keratinocyte Cell Growth and Differentiation through Regulation of p21(Waf1/CIP1)
por: Wong, Ping-Pui, et al.
Publicado: (2010) -
Regulation of epithelial differentiation and proliferation by the stroma – a role for the retinoblastoma protein
por: Pickard, Adam, et al.
Publicado: (2012) -
Lamprey IGF-Binding Protein-3 Has IGF-Dependent and -Independent Actions
por: Zhong, Yingbin, et al.
Publicado: (2017) -
p63 drives invasion in keratinocytes expressing HPV16 E6/E7 genes through regulation of Src-FAK signalling
por: Srivastava, Kirtiman, et al.
Publicado: (2015)